[Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)].

CONCLUSIONS: In this cohort of patients with type 2 diabetes mellitus receiving newly initiated insulin therapy, once-daily detemir improved the glycemic control, with low incidence of hypoglycemia and a significant reduction of the weight. PMID: 26054893 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26054893?dopt=Abstract

Source: Atencion Primaria - June 5, 2015 Category: Primary Care Authors: Orozco-Beltrán D, Artola-Menéndez S Tags: Aten Primaria Source Type: research